Zoetis beats top-line and bottom-line estimates; initiates FY26 outlook
Source: SeekingAlpha
2026-02-12 07:04:49 ET
- Zoetis press release ( ZTS ): Q4 Non-GAAP EPS of $1.48 beats by $0.08 .
- Revenue of $2.39B (+3.0% Y/Y) beats by $30M .
- Delivers 4% Organic Operational Growth in Revenue and 4% Organic Operational Growth in Adjusted Net Income for Fourth Quarter 2025.
- Provides Full Year 2026 Revenue Guidance of $9.825 - $10.025 Billion vs. $9.91B consensus , with Diluted EPS of $6.65 to $6.75 on a Reported Basis, or $7.00 to $7.10 on an Adjusted Basis vs. $6.82 consensus.
- Expects to Deliver 3% to 5% Organic Operational Growth in Revenue
Read the full article on Seeking Alpha
For further details see:
Zoetis beats top-line and bottom-line estimates; initiates FY26 outlook
Zoetis Inc. Class A
NASDAQ: ZTS
ZTS Trading
-1.47% G/L:
$115.1001 Last:
1,602,962 Volume:
$116.51 Open:
ZTS Latest News
ZTS Stock Data
$56,889,086,995
440,384,729
0.02%
903
N/A
Pharmaceuticals
Healthcare
US
Parsippany
